Profil
Richard E.
Armer, formerly a Research Director at Lectus Therapeutics Ltd., Principal at Pfizer Inc., Ardana Plc, and Oxagen Ltd., and Chief Scientific Officer at Redx Pharma Plc (2014-2024).
Anciens postes connus de Richard E. Armer
| Sociétés | Poste | Fin |
|---|---|---|
| REDX PHARMA LTD | Directeur Technique/Scientifique/R&D | 01/04/2024 |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
















